MoneyWorks4Me

Marksans Pharma informs about press release

25 Feb 2025 Evaluate
Marksans Pharma has informed that it enclosed a press release where in the Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..